These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 24637606)
1. Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii. Miquel S; Martín R; Bridonneau C; Robert V; Sokol H; Bermúdez-Humarán LG; Thomas M; Langella P Gut Microbes; 2014; 5(2):146-51. PubMed ID: 24637606 [TBL] [Abstract][Full Text] [Related]
2. Faecalibacterium prausnitzii and human intestinal health. Miquel S; Martín R; Rossi O; Bermúdez-Humarán LG; Chatel JM; Sokol H; Thomas M; Wells JM; Langella P Curr Opin Microbiol; 2013 Jun; 16(3):255-61. PubMed ID: 23831042 [TBL] [Abstract][Full Text] [Related]
3. Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Martín R; Bermúdez-Humarán LG; Langella P Front Microbiol; 2018; 9():346. PubMed ID: 29559959 [No Abstract] [Full Text] [Related]
4. Live Faecalibacterium prausnitzii induces greater TLR2 and TLR2/6 activation than the dead bacterium in an apical anaerobic co-culture system. Maier E; Anderson RC; Altermann E; Roy NC Cell Microbiol; 2018 Feb; 20(2):. PubMed ID: 29112296 [TBL] [Abstract][Full Text] [Related]
5. Butyrate mediates anti-inflammatory effects of Lenoir M; Martín R; Torres-Maravilla E; Chadi S; González-Dávila P; Sokol H; Langella P; Chain F; Bermúdez-Humarán LG Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 33054518 [TBL] [Abstract][Full Text] [Related]
6. The critical role of Faecalibacterium prausnitzii in human health: An overview. Leylabadlo HE; Ghotaslou R; Feizabadi MM; Farajnia S; Moaddab SY; Ganbarov K; Khodadadi E; Tanomand A; Sheykhsaran E; Yousefi B; Kafil HS Microb Pathog; 2020 Dec; 149():104344. PubMed ID: 32534182 [TBL] [Abstract][Full Text] [Related]
7. Action and function of Faecalibacterium prausnitzii in health and disease. Ferreira-Halder CV; Faria AVS; Andrade SS Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):643-648. PubMed ID: 29566907 [TBL] [Abstract][Full Text] [Related]
8. The abundance of fecal Faecalibacterium prausnitzii in relation to obesity and gender in Chinese adults. Feng J; Tang H; Li M; Pang X; Wang L; Zhang M; Zhao Y; Zhang X; Shen J Arch Microbiol; 2014 Jan; 196(1):73-7. PubMed ID: 24292154 [TBL] [Abstract][Full Text] [Related]
9. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. Miquel S; Leclerc M; Martin R; Chain F; Lenoir M; Raguideau S; Hudault S; Bridonneau C; Northen T; Bowen B; Bermúdez-Humarán LG; Sokol H; Thomas M; Langella P mBio; 2015 Apr; 6(2):. PubMed ID: 25900655 [TBL] [Abstract][Full Text] [Related]
10. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Lopez-Siles M; Khan TM; Duncan SH; Harmsen HJ; Garcia-Gil LJ; Flint HJ Appl Environ Microbiol; 2012 Jan; 78(2):420-8. PubMed ID: 22101049 [TBL] [Abstract][Full Text] [Related]
13. Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes. Cornuault JK; Petit MA; Mariadassou M; Benevides L; Moncaut E; Langella P; Sokol H; De Paepe M Microbiome; 2018 Apr; 6(1):65. PubMed ID: 29615108 [TBL] [Abstract][Full Text] [Related]
14. Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe. Heinken A; Khan MT; Paglia G; Rodionov DA; Harmsen HJ; Thiele I J Bacteriol; 2014 Sep; 196(18):3289-302. PubMed ID: 25002542 [TBL] [Abstract][Full Text] [Related]
15. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. Lopez-Siles M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M ISME J; 2017 Apr; 11(4):841-852. PubMed ID: 28045459 [TBL] [Abstract][Full Text] [Related]
16. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer. Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550 [TBL] [Abstract][Full Text] [Related]
17. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Quévrain E; Maubert MA; Michon C; Chain F; Marquant R; Tailhades J; Miquel S; Carlier L; Bermúdez-Humarán LG; Pigneur B; Lequin O; Kharrat P; Thomas G; Rainteau D; Aubry C; Breyner N; Afonso C; Lavielle S; Grill JP; Chassaing G; Chatel JM; Trugnan G; Xavier R; Langella P; Sokol H; Seksik P Gut; 2016 Mar; 65(3):415-425. PubMed ID: 26045134 [TBL] [Abstract][Full Text] [Related]
18. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. Rios-Covian D; Gueimonde M; Duncan SH; Flint HJ; de los Reyes-Gavilan CG FEMS Microbiol Lett; 2015 Nov; 362(21):. PubMed ID: 26420851 [TBL] [Abstract][Full Text] [Related]
19. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Sokol H; Pigneur B; Watterlot L; Lakhdari O; Bermúdez-Humarán LG; Gratadoux JJ; Blugeon S; Bridonneau C; Furet JP; Corthier G; Grangette C; Vasquez N; Pochart P; Trugnan G; Thomas G; Blottière HM; Doré J; Marteau P; Seksik P; Langella P Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16731-6. PubMed ID: 18936492 [TBL] [Abstract][Full Text] [Related]